Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: a prespecified secondary analysis of a randomized controlled clinical trial
Lynch L, Hogan AE, Duquette D, Lester C, Banks A, LeClair K, et al
Written informed consent was obtained from all of patients and our local institutional review board approved the study protocol (Institutional review board name, approval number, and approval date: Tokyo Yamate Medical Center Ethics Committee, J178, December 18, 2023)
Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-B signaling pathway inhibition